Scheme will be built at site next door to city’s airport
Interserve is preferred bidder for a £15m medicines centre near Glasgow.
Designed by architect BakerHicks, the Medicines Manufacturing Innovation Centre will manufacture fine chemicals and small molecule pharmaceuticals.
Spearheaded by the Centre for Process Innovation and Strathclyde University, the centre is being funded by pharmaceuticals firms AstraZeneca and GlaxoSmithKline along with UK Research and Innovation and Scottish Enterprise.
It will be built at the Advanced Manufacturing Innovation District Scotland, a developing 52 ha campus for cutting edge facilities next to Glasgow Airport.
A spokesman for Interserve said a final decision on the contract, which will be Interserve’s first job on the campus, is set to be made within the next month.